Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bastide Le Confort Medical (LTS:0IP1) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Bastide Le Confort Medical Forward PE Ratio Related Terms
Bastide Le Confort Medical Forward PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bastide Le Confort Medical Forward PE Ratio Chart
Bastide Le Confort Medical Annual Data
Trend
2025-06
Forward PE Ratio
9.12
Bastide Le Confort Medical Semi-Annual Data
2024-12
2025-06
2025-12
Forward PE Ratio
10.73
9.12
9.49
LTS:0IP1 vs MCK, CAH, COR: Forward PE Ratio Comparison
For the Medical Distribution subindustry, Bastide Le Confort Medical's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bastide Le Confort Medical Forward PE Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Bastide Le Confort Medical's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Bastide Le Confort Medical's Forward PE Ratio falls into.
Bastide Le Confort Medical Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Bastide Le Confort Medical (LTS:0IP1) has a Forward PE Ratio of 13.21 as of Jul. 18, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Bastide Le Confort Medical and its competitors. According to the industry distribution chart, Bastide Le Confort Medical ranks #20 out of 51 companies in the Medical Distribution industry, placing it in the top 39.2%.
Is Bastide Le Confort Medical's Forward PE Ratio too high?
Bastide Le Confort Medical's current Forward PE Ratio is 13.21. The Medical Distribution industry median Forward PE Ratio is 14.75. Bastide Le Confort Medical's value of 13.21 is 10.4% below this industry median. Based on the distribution chart, Bastide Le Confort Medical ranks #20 out of 51 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Bastide Le Confort Medical has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bastide Le Confort Medical's Forward PE Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Bastide Le Confort Medical ranks #20 out of 51 companies for Forward PE Ratio. This puts Bastide Le Confort Medical in the upper half of its industry. The industry median Forward PE Ratio is 14.75. Bastide Le Confort Medical's value of 13.21 is 10.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Distribution company?
The median Forward PE Ratio among Medical Distribution companies is 14.75, based on 51 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bastide Le Confort Medical's current Forward PE Ratio of 13.21 is 10.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Bastide Le Confort Medical and its competitors. For the Medical Distribution industry, the median Forward PE Ratio is 14.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bastide Le Confort Medical's current Forward PE Ratio is 13.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bastide Le Confort Medical stock overvalued right now?
Based on GuruFocus' analysis, Bastide Le Confort Medical (LTS:0IP1) is currently considered Fairly Valued. The stock's GF Value™ is €25.98, compared to a current price of €23.80 — trading 8.4% below its estimated fair value. The current Forward PE Ratio is 13.21 and 10.4% below the Medical Distribution industry median of 14.75. Bastide Le Confort Medical's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Bastide Le Confort Medical (LTS:0IP1), the current Forward PE Ratio is 13.21 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bastide Le Confort Medical (LTS:0IP1) Overvalued in 2026?
Based on GuruFocus' analysis, Bastide Le Confort Medical stock appears to be undervalued.
The current stock price of €23.80 is trading 8.4% below its estimated GF Value™ of €25.98.
GuruFocus considers Bastide Le Confort Medical to be Fairly Valued.
Key valuation signals for LTS:0IP1:
Forward PE Ratio: 13.21
GF Value™: €25.98 vs. price of €23.80 (8.4% below fair value)
Industry Position: 10.4% below the Medical Distribution median (#20 of 51)
No single metric tells the full story. See the LTS:0IP1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bastide Le Confort Medical SA is a France-based company that is engaged in the sale and rental of medical supplies and equipment for the home care of the elderly, sick and disabled. The company provides care equipment, such as hospital beds, personal assistance products, nutrition, insulin pumps, and syringe-drivers.
71GF Score
Get the complete analysis for LTS:0IP1
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0IP1 has been successfully added to your 
